Robert C. Goeltz II
Overview
Robert C. Goeltz II received an average of $1M in total compensation, including $387K in salary, at Unity Biotechnology between 2018 and 2019. Robert Goeltz also received an average of $2M at CytomX Therapeutics between 2015 and 2016.
Source: SEC filings on April 24, 2020 and May 9, 2017.
Related executives
We found 14 more executives who work or worked at Unity Biotechnology and CytomX Therapeutics.
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
Marcia Belvin
CytomX Therapeutics
Chief Scientific Officer
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
Carlos Campoy
CytomX Therapeutics
Chief Financial Officer
Lloyd Rowland
CytomX Therapeutics
Senior Vice President,
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
Anirvan Ghosh
Unity Biotechnology